Catalyst Pharmaceuticals Inc. closed $2.35 short of its 52-week high ($24.27), which the company reached on November 8th.

Researchers at Kyushu University have developed a device that combines a catalyst and microwave flow reaction to efficiently ...

Healthcare-focused AI startup Hippocratic AI has closed its Series B financing round, raising $141m, led by venture capital ...

Alnylam Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...

Rating on Friday, rising from 69 to 74. Please watch the video at Investors.com - How To Find Game-Changing Stocks This proprietary rating tracks technical performance by showing how a stock's price ...

The Dow Jones Industrial Average lost 696.75 points, or 1.63%, to close at 41,938.45. The S&P 500 slid 1.54% to 5,827.04, ...

Professor Douglas Boateng, Board Chairman of the Minerals Income Investment Fund (MIIF), has underscored the potential of ...

Crinetics Pharmaceuticals (CRNX) stock fell after Phase 2 results for its experimental drug atumelnant for congenital adrenal hyperplasia. Read more here.

The highly anticipated fourth edition of the Future Minerals Forum, set to take place from January 14 to 16, 2025, in Riyadh, ...

Catalyst Energy Infrastructure Fund earns a Below Average Process Pillar rating. The process is bolstered by the fund's impressive long-term risk-adjusted performance. This can be seen in its five ...

The U.S. dollar rallied on Friday after data showed the world's largest economy created more jobs than expected last month, reinforcing expectations that the Federal Reserve will pause its rate ...